You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

COZAAR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cozaar, and what generic alternatives are available?

Cozaar is a drug marketed by Organon and is included in one NDA.

The generic ingredient in COZAAR is losartan potassium. There are thirty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the losartan potassium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cozaar

A generic version of COZAAR was approved as losartan potassium by ALEMBIC PHARMS LTD on October 6th, 2010.

  Try a Trial

Drug patent expirations by year for COZAAR
Drug Prices for COZAAR

See drug prices for COZAAR

Drug Sales Revenue Trends for COZAAR

See drug sales revenues for COZAAR

Recent Clinical Trials for COZAAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Actuate TherapeuticsPhase 2
Colin D. Weekes, M.D.Phase 2
Lustgarten FoundationPhase 2

See all COZAAR clinical trials

Pharmacology for COZAAR

US Patents and Regulatory Information for COZAAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-002 Apr 14, 1995 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for COZAAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998 ⤷  Try a Trial ⤷  Try a Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995 ⤷  Try a Trial ⤷  Try a Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-002 Apr 14, 1995 ⤷  Try a Trial ⤷  Try a Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998 ⤷  Try a Trial ⤷  Try a Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-002 Apr 14, 1995 ⤷  Try a Trial ⤷  Try a Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-002 Apr 14, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for COZAAR

See the table below for patents covering COZAAR around the world.

Country Patent Number Title Estimated Expiration
South Korea 900005045 ⤷  Try a Trial
Israel 83153 SUBSTITUTED IMIDAZOLES,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ⤷  Try a Trial
Australia 685898 ⤷  Try a Trial
South Korea 900005020 ⤷  Try a Trial
Ireland 82833 PHARMACEUTICAL COMPOSITIONS COMPRISING ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLES AND DIURETICS ⤷  Try a Trial
Spain 2063734 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for COZAAR

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0480717 98C0025 Belgium ⤷  Try a Trial PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
0253310 C950009 Netherlands ⤷  Try a Trial PRODUCT NAME: LOSARTAN, DESGEWENST IN DE VORM VAN EEN AANVAARDBAAR ZOUT, IN HET BIJZONDER HET KALIUMZOUT; NAT. REGISTRATION NO/DATE: RVG 17617 19950314; FIRST REGISTRATION: SE 12209 19940902
0253310 96C0020 Belgium ⤷  Try a Trial PRODUCT NAME: KALII LOSARTAN; NAT. REGISTRATION NO/DATE: 922 IS 169 F3 19960130; FIRST REGISTRATION: SE 12209 19940902
0733366 98C0030 Belgium ⤷  Try a Trial PRODUCT NAME: KALII LOSARTAN, HYDROCHLOROTHIAZIDUM; NAT. REGISTRATION NO/DATE: 922 IS 174 F 3 19980223; FIRST REGISTRATION: FR 338 520.7 19950215
0733366 SZ 25/1998 Austria ⤷  Try a Trial PRODUCT NAME: LOSARTAN-KALIUM UND HYDROCHLOROTHIAZID
0253310 SZ 16/1996 Austria ⤷  Try a Trial PRODUCT NAME: LOSARTAN-KALIUM
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.